These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 8254397

  • 21. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
    [Abstract] [Full Text] [Related]

  • 22. Marrow toxicity and radiation absorbed dose estimates from rhenium-186-labeled monoclonal antibody.
    Breitz HB, Fisher DR, Wessels BW.
    J Nucl Med; 1998 Oct; 39(10):1746-51. PubMed ID: 9776281
    [Abstract] [Full Text] [Related]

  • 23. Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.
    Wilder RB, Langmuir VK, Mendonca HL, Goris ML, Knox SJ.
    Cancer Res; 1993 Jul 01; 53(13):3022-7. PubMed ID: 8319209
    [Abstract] [Full Text] [Related]

  • 24. A novel monoclonal antibody design for radioimmunotherapy.
    Forero A, Meredith RF, Khazaeli MB, Carpenter DM, Shen S, Thornton J, Schlom J, LoBuglio AF.
    Cancer Biother Radiopharm; 2003 Oct 01; 18(5):751-9. PubMed ID: 14629823
    [Abstract] [Full Text] [Related]

  • 25. Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.
    Knox SJ, Goris ML, Tempero M, Weiden PL, Gentner L, Breitz H, Adams GP, Axworthy D, Gaffigan S, Bryan K, Fisher DR, Colcher D, Horak ID, Weiner LM.
    Clin Cancer Res; 2000 Feb 01; 6(2):406-14. PubMed ID: 10690517
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibody.
    Meredith RF, LoBuglio AF, Plott WE, Orr RA, Brezovich IA, Russell CD, Harvey EB, Yester MV, Wagner AJ, Spencer SA.
    J Nucl Med; 1991 Jun 01; 32(6):1162-8. PubMed ID: 2045929
    [Abstract] [Full Text] [Related]

  • 27. 186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice.
    Beaumier PL, Venkatesan P, Vanderheyden JL, Burgua WD, Kunz LL, Fritzberg AR, Abrams PG, Morgan AC.
    Cancer Res; 1991 Jan 15; 51(2):676-81. PubMed ID: 1845957
    [Abstract] [Full Text] [Related]

  • 28. Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer.
    Bander NH, Milowsky MI, Nanus DM, Kostakoglu L, Vallabhajosula S, Goldsmith SJ.
    J Clin Oncol; 2005 Jul 20; 23(21):4591-601. PubMed ID: 15837970
    [Abstract] [Full Text] [Related]

  • 29. Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.
    Scott AM, Lee FT, Hopkins W, Cebon JS, Wheatley JM, Liu Z, Smyth FE, Murone C, Sturrock S, MacGregor D, Hanai N, Inoue K, Yamasaki M, Brechbiel MW, Davis ID, Murphy R, Hannah A, Lim-Joon M, Chan T, Chong G, Ritter G, Hoffman EW, Burgess AW, Old LJ.
    J Clin Oncol; 2001 Oct 01; 19(19):3976-87. PubMed ID: 11579119
    [Abstract] [Full Text] [Related]

  • 30. Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.
    Börjesson PK, Postema EJ, Roos JC, Colnot DR, Marres HA, van Schie MH, Stehle G, de Bree R, Snow GB, Oyen WJ, van Dongen GA.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3961S-72S. PubMed ID: 14506195
    [Abstract] [Full Text] [Related]

  • 31. Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250.
    Steffens MG, Boerman OC, Oosterwijk-Wakka JC, Oosterhof GO, Witjes JA, Koenders EB, Oyen WJ, Buijs WC, Debruyne FM, Corstens FH, Oosterwijk E.
    J Clin Oncol; 1997 Apr 01; 15(4):1529-37. PubMed ID: 9193349
    [Abstract] [Full Text] [Related]

  • 32. [186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer.
    Kievit E, van Gog FB, Schlüper HM, van Dongen GA, Pinedo HM, Boven E.
    Nucl Med Biol; 1998 Jan 01; 25(1):37-45. PubMed ID: 9466360
    [Abstract] [Full Text] [Related]

  • 33. Biodistribution and localization of radiolabeled NR-LU-10 Fab fragment in human breast cancer xenografts.
    Burak WE, DePalatis L, Nines R, Hitchcock C, Hinkle G, Houchens D, Farrar WB.
    Nucl Med Biol; 1998 Oct 01; 25(7):633-7. PubMed ID: 9804044
    [Abstract] [Full Text] [Related]

  • 34. Biodistribution and dosimetry of In-111/Y-90-HuCC49ΔCh2 (IDEC-159) in patients with metastatic colorectal adenocarcinoma.
    Shen S, Forero A, Meredith RF, LoBuglio AF.
    Cancer Biother Radiopharm; 2011 Feb 01; 26(1):127-33. PubMed ID: 21355784
    [Abstract] [Full Text] [Related]

  • 35. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
    van Gog FB, Visser GW, Klok R, van der Schors R, Snow GB, van Dongen GA.
    J Nucl Med; 1996 Feb 01; 37(2):352-62. PubMed ID: 8667076
    [Abstract] [Full Text] [Related]

  • 36. Decreased production of anti-mouse antibody after administration of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate to human.
    Yata Y, Otsuji E, Okamoto K, Tsuruta H, Kobayashi S, Toma A, Yamagishi H.
    Hepatogastroenterology; 2003 Feb 01; 50(49):80-4. PubMed ID: 12629996
    [Abstract] [Full Text] [Related]

  • 37. Radioimmunotherapy in patients with head and neck squamous cell carcinoma: initial experience.
    Colnot DR, Quak JJ, Roos JC, de Bree R, Wilhelm AJ, Snow GB, van Dongen GA.
    Head Neck; 2001 Jul 01; 23(7):559-65. PubMed ID: 11400244
    [Abstract] [Full Text] [Related]

  • 38. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
    Buchsbaum DJ, Brubaker PG, Hanna DE, Glatfelter AA, Terry VH, Guilbault DM, Steplewski Z.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):993s-999s. PubMed ID: 2297753
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of NR-LU-10 with the Neoprobe gamma detector in a mouse model.
    Lange MK, Sandhu A, Sampsel J, Hinkle G, Ignaszewski J, Martin E, Sandhu P, Martin EW.
    J Surg Res; 1993 Aug 01; 55(2):205-13. PubMed ID: 8412101
    [Abstract] [Full Text] [Related]

  • 40. Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapy.
    Leigh BR, Burke PA, Hong AM, O'Donnell RT, Howell LP, Miers LA, DeNardo GL, DeNardo SJ.
    Cancer Biother Radiopharm; 1999 Apr 01; 14(2):113-9. PubMed ID: 10850294
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.